Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study
(Q34601527)
scientific article published on 9 December 2008
scientific article published on 9 December 2008
Language: